Nanobiotix (STU:5NR) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:5NR Nanobiotix SA STU:5NR
27 GF Score
Price €34.62
! 3 Warning Signs
View Full Analysis

What is Nanobiotix Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:5NR vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Nanobiotix's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanobiotix Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanobiotix's Short Interest distribution charts can be found below:

* The bar in red indicates where Nanobiotix's Short Interest falls into.


STU:5NR
27GF Score
Nanobiotix SA STU:5NR
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanobiotix Business Description

Other Exchanges NBTX:USA0QAV:UKNANO:France
Address 60 Rue de Wattignies, Paris, FRA, 75012
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
27GF Score

Get the complete analysis for STU:5NR

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.62
Price